# Intranasal Ketamine in Treatment-Resistant Depression

> **NCT01304147** · NA · COMPLETED · sponsor: **James Murrough** · enrollment: 20 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Ketamine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01304147
- **Lead sponsor:** James Murrough
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01304147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01304147, "Intranasal Ketamine in Treatment-Resistant Depression". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01304147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*